Axiom/Command Center
+ New intake
← Back to dashboard

Assessment review

Clinical decision-support only — not a diagnosis. This report shows heuristic symptom-cluster pattern scores to support a clinician’s judgment. It does not diagnose disease, interpret labs, or recommend treatment or dosing. Phenotype weights are an unvalidated heuristic. Always correlate with full clinical evaluation.

Patient summary

Patient ref: TEST-THOMAS-COURT
Name: Thomas Court
Age: 45
Sex at birth: male
Assessment: initial · 2025-06-06 00:00:00+00:00
Recorded: 2026-06-15 00:05:11.367762+00:00
Scoring version: 1.0.0

Notes: Intake reflects lab-confirmed picture: Borrelia burgdorferi + co-infections (Bartonella), elevated urine mycotoxins (Ochratoxin A, Citrinin), EBV/Parvovirus B19 reactivation, elevated homocysteine. Symptom severities are representative for a test patient and should be confirmed by the provider.

Primary phenotype

Mitochondrial dysfunction
54/100 · moderate

Primary score 67/100 · separation 19 from runner-up

Secondary phenotype

Neuroinflammation

Secondary score 48/100

All phenotype scores

Mitochondrial dysfunction
67
Neuroinflammation
48
Mold / CIRS pattern
34
Immune dysregulation
29
Bartonella pattern
28
Connective tissue
11
Babesia pattern
9
Dysautonomia
4
Gut-immune
0
Metabolic dysfunction
0

Top contributing symptoms (primary phenotype)

SymptomSeverityWeightPoints
Fatigue339
Post-exertional malaise339
Unrefreshing sleep326
Exercise intolerance224
Muscle weakness224

Explanation

  • Primary phenotype "mitochondrial_dysfunction" scored 67/100.
  • Fatigue (severe) contributed 9 points to mitochondrial_dysfunction.
  • Post-exertional malaise (severe) contributed 9 points to mitochondrial_dysfunction.
  • Unrefreshing sleep (severe) contributed 6 points to mitochondrial_dysfunction.
  • Exercise intolerance (moderate) contributed 4 points to mitochondrial_dysfunction.
  • Muscle weakness (moderate) contributed 4 points to mitochondrial_dysfunction.
  • Secondary phenotype "neuroinflammation" scored 48/100 (separation 19).
  • Brain fog (severe) contributed 9 points to neuroinflammation.
  • Short-term memory impairment (moderate) contributed 6 points to neuroinflammation.
  • Slowed cognitive processing (moderate) contributed 4 points to neuroinflammation.

Reported factors (34)

Brain fog · severeFatigue · severeKnown mold exposure · severeKnown tick bite / removal · severeMigratory joint pain · severePost-exertional malaise · severeUnrefreshing sleep · severeChemical / scent sensitivity · moderateChronic sinus congestion · moderateExercise intolerance · moderateHeadache · moderateLight sensitivity · moderateMorning foot / sole pain · moderateMuscle weakness · moderateRecurrent infections · moderateSevere anxiety · moderateShin / bone pain · moderateShort-term memory impairment · moderateSlowed cognitive processing · moderateSustained high-stress period · moderateSwollen lymph nodes · moderateTime in water-damaged building · moderateTingling / numbness (neuropathy) · moderateBurning skin sensation · mildFrequent static shocks · mildFrequent urination / increased thirst · mildIce-pick / stabbing pains · mildLow-grade fevers · mildMetallic taste · mildNight sweats · mildRecent / prolonged antibiotic use · mildSudden rage / irritability episodes · mildSweats · mildVertigo · mild

Intake completeness

34 of 67 catalog factors rated (51%).

Missing recommended: Capture date/time

Clinical decision-support only — not a diagnosis. This report shows heuristic symptom-cluster pattern scores to support a clinician’s judgment. It does not diagnose disease, interpret labs, or recommend treatment or dosing. Phenotype weights are an unvalidated heuristic. Always correlate with full clinical evaluation.